{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:06:01Z","timestamp":1782219961751,"version":"3.54.5"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100001127","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001127","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The NADase sterile alpha and TIR motif containing 1 (Sarm1) protein drives axon degeneration after injury. Loss or inhibition of Sarm1 structurally protects axons after sciatic nerve transection (SNT) in vivo but whether Sarm1 also drives functional loss after nerve injury is less clear. We established compound muscle action potential (CMAP) as a novel functional correlate of Sarm1 activation in a SNT mouse model and evaluated its relationship with biochemical and a novel Cellpose-based histological axon detection measure. CMAP amplitudes were elicited 8\u2009h post-SNT but reached near-floor levels by 24\u2009h. Decreases in CMAP amplitude are delayed in a gene dose-dependent manner in Sarm1 knockout mice or by pharmacological Sarm1 inhibition. Myelinated axon density, the NAD hydrolysis product cyclic adenosine diphosphate ribose (cADPR), and the axon degeneration plasma biomarker neurofilament light (NfL) were all altered in a Sarm1-dependent manner. In wild type mice, axon density and NfL were altered at time points after that of cADPR and functional loss, indicating that functional deficits preceded structural deficits. We conclude that functional and structural declines after injury are delayed by Sarm1 inhibition and that CMAP measures after SNT can serve as a novel, preclinical, functional, pharmacodynamic readout for Sarm1 inhibition.<\/jats:p>","DOI":"10.1093\/jnen\/nlaf066","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:15:14Z","timestamp":1749208514000},"page":"998-1012","source":"Crossref","is-referenced-by-count":1,"title":["Compound muscle action potential as an early functional in vivo measure of Sarm1 inhibition after sciatic nerve transection"],"prefix":"10.1093","volume":"84","author":[{"given":"Seong Kwon","family":"Hur","sequence":"first","affiliation":[{"name":"Department of Neuroscience, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca R","family":"Leahey","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Geringer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hoon","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda","family":"Hernandez-Barry","sequence":"additional","affiliation":[{"name":"Department of Biochemical and Cellular Pharmacology, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichu","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Biochemical and Cellular Pharmacology, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S","family":"Sawyer","sequence":"additional","affiliation":[{"name":"Department of Biochemical and Cellular Pharmacology, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Baca","sequence":"additional","affiliation":[{"name":"Department of Pathology, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Nespi","sequence":"additional","affiliation":[{"name":"Department of Small Molecule Pharmaceutical Sciences, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond R","family":"Asuncion","sequence":"additional","affiliation":[{"name":"Department of Transgenic Technology, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ManKin","family":"Choy","sequence":"additional","affiliation":[{"name":"Department of Translational Imaging, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Maksymetz","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T","family":"Vito","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Imperio","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Stark","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Discovery Chemistry, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan K","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Discovery Chemistry, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Translational Imaging, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Ly","sequence":"additional","affiliation":[{"name":"Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia A","family":"Nugent","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Department of Pathology, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora I","family":"Hinz","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5039-5010","authenticated-orcid":false,"given":"Martin","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Genentech, Inc. , South San Francisco, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"2025101703521314700_nlaf066-B1","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neuron.2017.02.022","article-title":"The SARM1 toll\/interleukin-1 receptor domain possesses intrinsic NAD(+) cleavage activity that promotes pathological axonal degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"key":"2025101703521314700_nlaf066-B2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1223899","article-title":"dSarm\/Sarm1 is required for activation of an injury-induced axon death pathway","volume":"337","author":"Osterloh","year":"2012","journal-title":"Science"},{"key":"2025101703521314700_nlaf066-B3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.conb.2021.05.004","article-title":"SARM1 signaling mechanisms in the injured nervous system","volume":"69","author":"Sambashivan","year":"2021","journal-title":"Curr Opin Neurobiol"},{"key":"2025101703521314700_nlaf066-B4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrn3680","article-title":"Wallerian degeneration: an emerging axon death pathway linking injury and disease","volume":"15","author":"Conforti","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"2025101703521314700_nlaf066-B5","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1093\/brain\/awab184","article-title":"Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy","volume":"144","author":"Bosanac","year":"2021","journal-title":"Brain"},{"key":"2025101703521314700_nlaf066-B6","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.neuron.2022.08.017","article-title":"Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease","volume":"110","author":"Bratkowski","year":"2022","journal-title":"Neuron"},{"key":"2025101703521314700_nlaf066-B7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1084\/jem.20181040","article-title":"Gene therapy targeting SARM1 blocks pathological axon degeneration in mice","volume":"216","author":"Geisler","year":"2019","journal-title":"J Exp Med"},{"key":"2025101703521314700_nlaf066-B8","doi-asserted-by":"crossref","first-page":"e2424232024","DOI":"10.1523\/JNEUROSCI.2424-23.2024","article-title":"Context-specific stress causes compartmentalized SARM1 activation and local degeneration in cortical neurons","volume":"44","author":"Hinz","year":"2024","journal-title":"J Neurosci"},{"key":"2025101703521314700_nlaf066-B9","author":"Leahey","year":"2024"},{"key":"2025101703521314700_nlaf066-B10","doi-asserted-by":"crossref","first-page":"e72823","DOI":"10.7554\/eLife.72823","article-title":"Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1","volume":"10","author":"Loreto","year":"2021","journal-title":"Elife"},{"key":"2025101703521314700_nlaf066-B11","doi-asserted-by":"crossref","first-page":"113252","DOI":"10.1016\/j.expneurol.2020.113252","article-title":"cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons","volume":"329","author":"Sasaki","year":"2020","journal-title":"Exp Neurol"},{"key":"2025101703521314700_nlaf066-B12","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1093\/hmg\/ddy260","article-title":"Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"27","author":"Peters","year":"2018","journal-title":"Hum Mol Genet"},{"key":"2025101703521314700_nlaf066-B13","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/cne.22645","article-title":"Sciatic nerve transection triggers release and intercellular transfer of a genetically expressed macromolecular tracer in dorsal root ganglia","volume":"519","author":"Braz","year":"2011","journal-title":"J Comp Neurol"},{"key":"2025101703521314700_nlaf066-B14","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.molcel.2022.03.007","article-title":"Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules","volume":"82","author":"Shi","year":"2022","journal-title":"Mol Cell"},{"key":"2025101703521314700_nlaf066-B15","doi-asserted-by":"crossref","first-page":"e2208457119","DOI":"10.1073\/pnas.2208457119","article-title":"Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain","volume":"119","author":"Feldman","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025101703521314700_nlaf066-B16","doi-asserted-by":"crossref","first-page":"110108","DOI":"10.1016\/j.celrep.2021.110108","article-title":"Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration","volume":"37","author":"Gould","year":"2021","journal-title":"Cell Rep"},{"key":"2025101703521314700_nlaf066-B17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.omtn.2023.02.029","article-title":"Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies","volume":"32","author":"Liu","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"2025101703521314700_nlaf066-B18","doi-asserted-by":"crossref","first-page":"e2347232024","DOI":"10.1523\/JNEUROSCI.2347-23.2024","article-title":"Neutral or detrimental effects of TREM2 agonist antibodies in preclinical models of Alzheimer's disease and multiple sclerosis","volume":"44","author":"Etxeberria","year":"2024","journal-title":"J Neurosci"},{"key":"2025101703521314700_nlaf066-B19","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2337\/db18-1233","article-title":"Sarm1 gene deficiency attenuates diabetic peripheral neuropathy in mice","volume":"68","author":"Cheng","year":"2019","journal-title":"Diabetes"},{"key":"2025101703521314700_nlaf066-B20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/jns.12219","article-title":"Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy","volume":"22","author":"Turkiew","year":"2017","journal-title":"J Peripher Nerv Syst"},{"key":"2025101703521314700_nlaf066-B21","doi-asserted-by":"crossref","first-page":"113607","DOI":"10.1016\/j.expneurol.2021.113607","article-title":"Protection against oxaliplatin-induced mechanical and thermal hypersensitivity in Sarm1(-\/-) mice","volume":"338","author":"Gould","year":"2021","journal-title":"Exp Neurol"},{"key":"2025101703521314700_nlaf066-B22","first-page":"52899","article-title":"Electrophysiological motor unit number estimation (MUNE) measuring compound muscle action potential (CMAP) in mouse hindlimb muscles","volume":"103","author":"Arnold","year":"2015","journal-title":"J Vis Exp"},{"key":"2025101703521314700_nlaf066-B23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cnp.2024.04.002","article-title":"Revisiting the compound muscle action potential (CMAP)","volume":"9","author":"Barkhaus","year":"2024","journal-title":"Clin Neurophysiol Pract"},{"key":"2025101703521314700_nlaf066-B24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/B978-0-444-52902-2.00006-0","article-title":"Neurophysiological approach to disorders of peripheral nerve","volume":"115","author":"Crone","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"2025101703521314700_nlaf066-B25","doi-asserted-by":"crossref","first-page":"108362","DOI":"10.1016\/j.isci.2023.108362","article-title":"TMEM106B reduction does not rescue GRN deficiency in iPSC-derived human microglia and mouse models","volume":"26","author":"Dominguez","year":"2023","journal-title":"iScience"},{"key":"2025101703521314700_nlaf066-B26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/mus.24237","article-title":"Presymptomatic electrophysiological tests predict clinical onset and survival in SOD1(G93A) ALS mice","volume":"50","author":"Mancuso","year":"2014","journal-title":"Muscle Nerve"},{"key":"2025101703521314700_nlaf066-B27","first-page":"57741","article-title":"In vivo electrophysiological measurement of compound muscle action potential from the forelimbs in mouse models of motor neuron degeneration","volume":"136","author":"Pollari","year":"2018","journal-title":"J Vis Exp"},{"key":"2025101703521314700_nlaf066-B28","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.clinph.2019.05.008","article-title":"Standards for quantification of EMG and neurography","volume":"130","author":"Stalberg","year":"2019","journal-title":"Clin Neurophysiol"},{"key":"2025101703521314700_nlaf066-B29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1113\/jphysiol.1952.sp004716","article-title":"Measurement of current-voltage relations in the membrane of the giant axon of Loligo","volume":"116","author":"Hodgkin","year":"1952","journal-title":"J Physiol"},{"key":"2025101703521314700_nlaf066-B30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/brain\/awn332","article-title":"Motor axon excitability during Wallerian degeneration","volume":"132","author":"Moldovan","year":"2009","journal-title":"Brain"},{"key":"2025101703521314700_nlaf066-B31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1529-8027.2012.00418.x","article-title":"Patterns of nerve injury and neuropathic pain in ischemic neuropathy after ligation-reperfusion of femoral artery in mice","volume":"17","author":"Lee","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"2025101703521314700_nlaf066-B32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/mus.27756","article-title":"Retrograde labeling correlates with motor unit number estimation in rapid-stretch nerve injury","volume":"67","author":"Yeoh","year":"2023","journal-title":"Muscle Nerve"},{"key":"2025101703521314700_nlaf066-B33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12031-015-0648-9","article-title":"Ectopic muscle expression of neurotrophic factors improves recovery after nerve injury","volume":"58","author":"Glat","year":"2016","journal-title":"J Mol Neurosci"},{"key":"2025101703521314700_nlaf066-B34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/mus.880150610","article-title":"Wallerian degeneration in human nerves: serial electrophysiological studies","volume":"15","author":"Chaudhry","year":"1992","journal-title":"Muscle Nerve"},{"key":"2025101703521314700_nlaf066-B35","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1084\/jem.20070868","article-title":"MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival","volume":"204","author":"Kim","year":"2007","journal-title":"J Exp Med"},{"key":"2025101703521314700_nlaf066-B36","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41592-022-01663-4","article-title":"Cellpose 2.0: how to train your own model","volume":"19","author":"Pachitariu","year":"2022","journal-title":"Nat Methods"},{"key":"2025101703521314700_nlaf066-B37","author":"Wightman","year":"2019"},{"key":"2025101703521314700_nlaf066-B38","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025101703521314700_nlaf066-B39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders\u2014towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"2025101703521314700_nlaf066-B40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13395-024-00349-z","article-title":"AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice","volume":"14","author":"Chen","year":"2024","journal-title":"Skelet Muscle"},{"key":"2025101703521314700_nlaf066-B41","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41418-020-00625-7","article-title":"Genetic inactivation of RIP1 kinase does not ameliorate disease in a mouse model of ALS","volume":"28","author":"Dominguez","year":"2021","journal-title":"Cell Death Differ"},{"key":"2025101703521314700_nlaf066-B42","doi-asserted-by":"crossref","first-page":"e65976","DOI":"10.1371\/journal.pone.0065976","article-title":"Electrophysiologic biomarkers for assessing disease progression and the effect of riluzole in SOD1 G93A ALS mice","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"2025101703521314700_nlaf066-B43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/ane.12510","article-title":"CMAP decrement as a potential diagnostic marker for ALS","volume":"134","author":"Mori","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"2025101703521314700_nlaf066-B44","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1038\/s41598-019-39313-z","article-title":"Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study","volume":"9","author":"Musaro","year":"2019","journal-title":"Sci Rep"},{"key":"2025101703521314700_nlaf066-B45","doi-asserted-by":"crossref","first-page":"1059743","DOI":"10.3389\/fneur.2022.1059743","article-title":"Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography","volume":"13","author":"Nagy","year":"2022","journal-title":"Front Neurol"},{"key":"2025101703521314700_nlaf066-B46","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ebiom.2015.11.022","article-title":"Flecainide in amyotrophic lateral sclerosis as a neuroprotective strategy (FANS): a randomized placebo-controlled trial","volume":"2","author":"Park","year":"2015","journal-title":"EBioMedicine"},{"key":"2025101703521314700_nlaf066-B47","doi-asserted-by":"crossref","first-page":"101385","DOI":"10.1016\/j.isci.2020.101385","article-title":"DOK7 gene therapy enhances neuromuscular junction innervation and motor function in aged mice","volume":"23","author":"Ueta","year":"2020","journal-title":"iScience"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/84\/11\/998\/63445731\/nlaf066.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/84\/11\/998\/63445731\/nlaf066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T07:52:23Z","timestamp":1760687543000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/84\/11\/998\/8157795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6,6]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlaf066","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,6,6]]}}}